NIH clinical trial of investigational vaccine for COVID-19 begins
$ 16.50 · 4.5 (794) · In stock
Study enrolling Seattle-based healthy adult volunteers.
Phase III clinical trial for respiratory syncytial virus (RSV) vaccine begins
Vaccines, Free Full-Text
Genome based Evolutionary study of SARS-CoV-2 towards the Prediction of Epitope Based Chimeric Vaccine
Review of trials currently testing treatment and prevention of COVID-19 - ScienceDirect
Academy of Europe: COVID-19 Bulletin
Management of COVID-19: current status and future prospects - ScienceDirect
COVID-19 mitigation: nanotechnological intervention, perspective, and future scope - Materials Advances (RSC Publishing) DOI:10.1039/D2MA00797E
AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial
An overview of key potential therapeutic strategies for combat in the COVID-19 battle - RSC Advances (RSC Publishing) DOI:10.1039/D0RA05434H
SARS‐CoV‐2: What do we know so far? - Khedkar - 2020 - Acta Physiologica - Wiley Online Library
Investigational COVID-19 vaccine well-tolerated in older adults
Review of trials currently testing treatment and prevention of COVID-19 - ScienceDirect
UM Begins Second COVID-19 Vaccine Clinical Trial
A clinical trial of an investigational COVID-19 vaccine begins